Clinical trial
Dexcom CGM as Preventative Diagnostic Tool in Steroid-Induced Hyperglycemia During Interventional Pain Management Procedure
NCT06628284 is registered in ClinicalTrials.gov with Mahesh Pattabiraman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexcom CGM as Preventative Diagnostic Tool in Steroid-Induced Hyperglycemia During Interventional Pain Management Procedure
- Lead sponsor
- Mahesh Pattabiraman
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 17, 2024
- Completion date
- March 21, 2025
- Enrollment
- 71 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, pain management